Investor letter: Thrive's 2022 early-stage $516M fund that invested in OpenAI and SpaceX was worth $3.7B+ as of the end of June, net of fees and other charges
Context & Ripple Effects
Thrive’s reported mark on its 2022 early-stage vehicle follows a run of increasingly large OpenAI commitments, including its investment in OpenAI’s 2024 financing with a follow-on option and a later $1B OpenAI investment at a $285B valuation. The fund also holds SpaceX, making the disclosure a concentrated snapshot of Thrive’s exposure to two high-profile private companies.
The result matters alongside Thrive’s expansion in fund scale: the firm had already raised separate early- and late-stage funds after backing OpenAI, and the reported net value gives prospective limited partners a concrete performance datapoint rather than only a fundraising narrative.
First-order effects
- Thrive can present the 2022 fund’s value above $3.7B net of fees and charges as evidence of its investment performance to existing and prospective limited partners.
- Investors in the $516M vehicle receive a substantially higher reported fund valuation, while Thrive’s exposure remains tied to the private valuations of OpenAI and SpaceX rather than a disclosed cash exit.
Second-order effects
- The performance mark strengthens Thrive’s position as it deploys larger pools of capital, raising the competitive pressure on other growth investors seeking allocations in scarce frontier-company financings.
- OpenAI’s ability to attract large repeat checks from Thrive becomes more consequential for other investors, since access at earlier valuations can shape the relative returns that fund managers show to limited partners.
Third-order effects
- If repeat marks and follow-on investments continue to reward early backers, frontier-company financing is likely to concentrate further among managers that secured early access and can sustain larger subsequent checks.
- Private-fund performance will become more tightly linked to a small set of highly valued technology holdings, increasing the importance of reported valuation marks in fundraising competition.
The trend: Frontier-technology investing is concentrating returns and fundraising leverage among managers with early stakes and repeat access to the largest private companies.